Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliers
{{output}}
Drug development groups are close to discovering another pot of gold-a therapeutic target-similar to the success of imatinib (Gleevec) in the field of cancer biology. Modern molecular biology has improved cancer therapy through the identification of more pharm... ...
